Found: 38
Select item for more details and to access through your institution.
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study.
- Published in:
- Cancer Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/cnr2.1367
- By:
- Publication type:
- Article
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-24812-3
- By:
- Publication type:
- Article
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 831, doi. 10.1007/s10637-019-00840-1
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077088
- By:
- Publication type:
- Article
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5427, doi. 10.3390/cancers13215427
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 3991, doi. 10.3390/cancers13163991
- By:
- Publication type:
- Article
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3741, doi. 10.3390/cancers13153741
- By:
- Publication type:
- Article
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 215, doi. 10.1111/liv.14270
- By:
- Publication type:
- Article
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 670, doi. 10.1007/s10637-014-0082-9
- By:
- Publication type:
- Article
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 399, doi. 10.1007/s10637-012-9890-y
- By:
- Publication type:
- Article
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 1, p. 137, doi. 10.1007/s10637-009-9347-0
- By:
- Publication type:
- Article
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.627819
- By:
- Publication type:
- Article
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies.
- Published in:
- Clinical Colorectal Cancer, 2015, v. 14, n. 1, p. 18, doi. 10.1016/j.clcc.2014.12.001
- By:
- Publication type:
- Article
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 455, doi. 10.1002/cpt.2444
- By:
- Publication type:
- Article
Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 6, p. 1456, doi. 10.1002/cpt.1331
- By:
- Publication type:
- Article
The yield of chest computed tomography in patients with locally advanced pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2020, v. 122, n. 3, p. 450, doi. 10.1002/jso.25968
- By:
- Publication type:
- Article
FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.
- Published in:
- Journal of Surgical Oncology, 2018, v. 118, n. 6, p. 1021, doi. 10.1002/jso.25233
- By:
- Publication type:
- Article
A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 435, doi. 10.1007/s00280-007-0486-8
- By:
- Publication type:
- Article
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension.
- Published in:
- 2023
- By:
- Publication type:
- journal article
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 7, p. 1010, doi. 10.1038/s41416-021-01657-7
- By:
- Publication type:
- Article
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 7, p. 1037, doi. 10.1007/s40262-024-01390-3
- By:
- Publication type:
- Article
Sorafenib Induced Thyroiditis in Two Patients with Hepatocellular Carcinoma.
- Published in:
- Thyroid, 2011, v. 21, n. 2, p. 197, doi. 10.1089/thy.2010.0234
- By:
- Publication type:
- Article
Are we SHARP enough? The importance of adequate patient selection in sorafen ib treatment for hepatocellular carcinoma.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1467, doi. 10.1080/0284186X.2018.1479070
- By:
- Publication type:
- Article
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e639, doi. 10.1002/onco.13674
- By:
- Publication type:
- Article
Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 399, doi. 10.1634/theoncologist.2017-0682
- By:
- Publication type:
- Article
Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 323, doi. 10.1634/theoncologist.2012-0334
- By:
- Publication type:
- Article
Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study.
- Published in:
- Oncologist, 2006, v. 11, n. 8, p. 944, doi. 10.1634/theoncologist.11-8-944
- By:
- Publication type:
- Article
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1199-8
- By:
- Publication type:
- Article
Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers.
- Published in:
- Digestive Surgery, 2013, v. 29, n. 6, p. 522, doi. 10.1159/000348669
- By:
- Publication type:
- Article
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
- Published in:
- Molecular Oncology, 2012, v. 6, n. 2, p. 196, doi. 10.1016/j.molonc.2012.01.009
- By:
- Publication type:
- Article